Correlation Between Akero Therapeutics and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and TG Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and TG Therapeutics.
Diversification Opportunities for Akero Therapeutics and TG Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Akero and TGTX is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and TG Therapeutics go up and down completely randomly.
Pair Corralation between Akero Therapeutics and TG Therapeutics
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.11 times less return on investment than TG Therapeutics. In addition to that, Akero Therapeutics is 1.21 times more volatile than TG Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 1,839 in TG Therapeutics on November 2, 2024 and sell it today you would earn a total of 1,342 from holding TG Therapeutics or generate 72.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. TG Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| TG Therapeutics |
Akero Therapeutics and TG Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and TG Therapeutics
The main advantage of trading using opposite Akero Therapeutics and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |